Profile
ABVX VRTX REGN SGEN ALNY ARGX
Company Name ABIVAX SA Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. Alnylam Pharmaceuticals, Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $378.72M $116.96B $54.11B $43.15B $38.15B $33.66B
Employees 0.07K 6.10K 15.16K 3.26K 2.23K 1.60K
CEO Mr. Marc M. P. de Garidel M.B.A. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Dr. Yvonne L. Greenstreet M.B.A., M.D. Mr. Timothy Van Hauwermeiren EMBA, M.Sc.
Ratings
Trading
ABVX VRTX REGN SGEN ALNY ARGX
Last Close $7.05 $445.82 $520.29 $228.74 $321.94 $560.53
High 52 $13.75 $516.74 $1201.76 $228.74 $325 $671.75
Low 52 $5.24 $396.64 $482.92 $228.74 $224.58 $430.04
Price vs. 52 Week High -48.73 % -13.72 % -56.71 % 0 % -0.94 % -16.56 %
Price vs. 52 Week Low 34.54 % 12.4 % 7.74 % 0 % 43.35 % 30.34 %
Total Return
ABVX VRTX REGN SGEN ALNY ARGX
1 Month Return 24.34 % 2.25 % -11.57 % 0 % 11.03 % -4.61 %
3 Month Return -0.84 % -10.89 % -18.72 % 0 % 19.59 % -3.96 %
6 Month Return -7.96 % 8.56 % -27.4 % 0 % 32.76 % -11.31 %
9 Month Return -39.22 % -3.74 % -49.97 % 0 % 17.25 % 6.85 %
YTD Return -3.69 % 10.71 % -26.96 % 0 % 36.82 % -8.86 %
1 Year Return -45.6 % -5.95 % -51.34 % 0 % 31.31 % 25.71 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
ABVX VRTX REGN SGEN ALNY ARGX
Dividend Yield Percentage (TTM) - - 0.35 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -242.99 % -3.53 % 3.85 % -5.87 % -1.49 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Growth
ABVX VRTX REGN SGEN ALNY ARGX
Asset Growth -37.25 % -0.87 % 12.32 %
Gross Profit Growth 135.94 % 10.25 % 26.81 %
Revenue Growth 133.54 % 11.66 % 22.97 %
Revenue 3 Year 7651.69 % 45.6 % 147.1 %
Revenue 5 Year 8965.63 % 163.93 % 775.72 %
Revenue 10 Year 2264.08 % 1632.15 % 2487.4 %
EBIT Growth -29.17 % -93.69 % 24.59 %
Net Income Growth -19.29 % -114.8 % 36.82 %
Net Income 3 Yeari Growth Per Share -13.25 % -122.89 % 69.73 %
Net Income 5 Yeari Growth Per Share -11.16 % -145.38 % 73.13 %
Net Income 10 Yeari Growth Per Share -220.01 % 33.84 % 55.09 %
Operating Income Growth -35.81 % -106.08 % 37.31 %
Operating Cash Flow Growth (CFG) -54.06 % -113.93 % -107.98 %
Operating 3 Year CFG 10.32 % -118.65 % 98.8 %
Operating 5 Year CFG -8.35 % -131.3 % 97.44 %
Operating 10 Year CFG -585.57 % 12.43 % 97.08 %
EPS Growth 18.37 % -114.8 % 38.64 %
EPS Diluted Growth 18.37 % -114.97 % 38.64 %
Book Value Per Share -85.86 % -6.59 % 157.17 %
Share Holder 3 Year Equity Growth Per Share -69.71 % 62.6 % -89.42 %
Share Holder 5 Year Equity Growth Per Share -57.83 % 168.85 % -96.01 %
Share Holder 10 Year Equity Growth Per Share -82.41 % 1265.7 % -95.83 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth 75.54 % 116.42 % -51.69 %
Free Cash Flow Growth -54.29 % -124.1 % -201.54 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
ABVX VRTX REGN SGEN ALNY ARGX
Gross Profit Margin TTM 92.28 % 86.03 % 84.94 % 79.1 % 86.01 % 46.33 %
Return on Assets TTM -85.88 % -4.32 % 11.98 % -16.61 % -6.4 % 13.45 %
Return on Equity TTM -211 % -6.25 % 14.77 % -20.8 % -509.33 % 16.83 %
Return on Capital Employed TTM -160.59 % -3.89 % 11.35 % -21.46 % -3.68 % -0.5 %
Net Income Per EBT TTM 96.36 % 329.41 % 90.27 % 101.33 % 75.89 % 25990.14 %
EBT Per Ebit TTM 102.39 % 40.44 % 129.3 % 98.26 % 308.03 % -11.64 %
EBIT Per Revenue TTM -2632.15 % -6.69 % 27.37 % -31.24 % -4.91 % -1.24 %
Cash Flow To Debt Ratio TTM -161.67 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Receivables Turnover TTM 0.43 6.15 2.53 3.91 5.62 2.36
Payables Turnover TTM 0.02 3.49 3.01 1.97 3.37 2.39
Inventory Turnover TTM - 1.14 0.66 0.96 5.01 2.93
Fixed Asset Turnover TTM 254.54 % 421.34 % 300.07 % 665.41 % 337.41 % 5106.8 %
Asset Turnover TTM 3.31 % 48.51 % 37.52 % 53.41 % 55.72 % 35.83 %
Operating Cash Flow Per Share TTM -2.46 -3.82 37.05 -2.46 -0.35 -1.07
Free Cash Flow Per Share TTM -2.47 -4.9 28.3 -2.88 -0.58 -1.09
Cash Per Share TTM 228.35 % 2413.86 % 7825.12 % 939.52 % 2024.29 % 4688.94 %
Operating Cash Flow Sales Ratio TTM -2291.69 % -8.83 % 28.06 % -23.12 % -1.92 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.41 % 128.33 % 76.4 % 117.04 % 167.11 % 102.26 %
Cash Flow Coverage Ratios TTM -161.67 % -59.44 % 146.15 % -1043.73 % -3.47 % -201.37 %
Price To Free Cash Flows Ratio TTM -2.13 -92.97 17.92 -81.26 -506.05 -433.65
Price To Operating Cash Flows Ratio TTM -2.13 -119.36 13.76 -93.1 -841.05 -515.25
Price Cash Flow Ratio TTM -2.13 -119.36 13.76 -93.1 -841.05 -515.25
Income Statement (TTM)
ABVX VRTX REGN SGEN ALNY ARGX
Revenue $0.01B $11.02B $14.2B $1.96B $2.25B $2.19B
Gross Profit $0.01B $9.49B $12.23B $1.55B $1.92B $1.96B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 85.62% 89.62%
EBITDA $-0.17B $0.49B $5.32B $-0.62B $-0.18B $0.11B
Net Income $-0.18B $-0.54B $4.41B $-0.61B $-0.28B $0.83B
EPS Diluted -2.8 -2.08 38.34 -3.3 -2.16 12.78
Balance Sheet (MRQ)
ABVX VRTX REGN SGEN ALNY ARGX
Long Term Debt $0.05B $1.66B $1.98B $0.04B $0B $0.03B
Total Liabilities $0.16B $6.12B $8.41B $0.87B $4.17B $0.7B
Total Equity $0.04B $16.41B $29.35B $2.8B $0.07B $5.5B
Total Investments $0B $6.65B $15.42B $1.42B $1.73B $1.93B
Total Debt $0.1B $1.75B $2.7B $0.04B $1.3B $0.04B
Total Assets $0.21B $22.53B $37.76B $3.67B $4.3B $6.2B
Cash Flow Statement (TTM)
ABVX VRTX REGN SGEN ALNY ARGX
Net Income $-0.18B $-0.54B $4.41B $-0.61B $-0.28B $-0.02B
Inventory $0B $-0.52B $-0.62B $-0.23B $0.01B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.15B $-0.49B $4.42B $-0.45B $-0.01B $-0.08B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.03B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 40.67
AARD Aardvark Therapeutics, Inc. Common Stock 13.95
ABCL AbCellera Biologics Inc. 3.7376
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.91
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0292
ABSI Absci Corporation 2.71
ABUS Arbutus Biopharma Corporation 3.195
ABVC ABVC BioPharma, Inc. 2.175
ACAD ACADIA Pharmaceuticals Inc. 22.22
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.6714
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.49
ACIU AC Immune SA 2.095
ACLX Arcellx, Inc. 64.835
ETFs With Exposure to ABVX
Ticker ETF Name Weight Percentage Price
DBEZ Xtrackers MSCI Eurozone Hedged Equity ETF 0 50.44
BOUT Innovator IBD Breakout Opportunities ETF 2.56 36.16
SPEU SPDR Portfolio Europe ETF 0.001349 47.87
SXRJ.DE iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0665 315.15
CES1.L iShares VII PLC - iShares MSCI EMU Small Cap UCITS ETF EUR (Acc) 0.0539 26855
Unlock